Navigation Links
It Must Be Friday Night: Pres. Obama to Issue Deadly Executive Order
Date:3/6/2009

WASHINGTON, March 6 /PRNewswire-USNewswire/ -- Family Research Council (FRC) President Tony Perkins responded to President Obama's move announced late Friday to overturn President Bush's policy that allowed funding of human embryonic stem cell research without encouraging the destruction of human embryos. In August 2001, President Bush for the first time allowed federal funding for embryonic stem cell research. Since that decision, funding has increased to over $40 million per year on human embryonic stem cells, new methods have been developed to create embryonic-like stem cells without harming or destroying human embryos, and adult stem cells have been used to treat over 70 diseases in human patients.

(Logo: http://www.newscom.com/cgi-bin/prnh/20080930/FRCLOGO )

Tony Perkins, President of Family Research Council, released the following statement:

"It must be Friday night because word leaks of yet another deadly executive order by President Obama. Friday night orders include rescinding the Mexico City Policy, eroding conscience protections for health care providers and now word of greenlighting funding for experiments that encourage human embryo destruction. Today's news that President Obama will open the door to direct taxpayer funds for embryonic stem cell research that encourages the destruction of human embryos is a slap in the face to Americans who believe in the dignity of all human life.

"I believe it is unethical to use human life, even young embryonic life, to advance science. While such research is unfortunately legal, taxpayers should not have to foot the bill for experiments that require the destruction of human life. President Obama's policy change is especially troubling given the significant adult stem cell advances that are being used to treat patients now without harming or destroying human embryos.

"Despite the significant advances using adult stem cells to treat patients, and new techniques to create stem cells from any patient, President Obama will choose to direct taxpayer's money to experiments that represent the poorest stem cell science.

"We should be increasing funding for adult stem cell treatments, which have been used to treat patients for over 70 diseases and conditions, and we should fund the historic achievements in reprogramming ordinary skin cells into embryonic-like stem cells without compromising ethics by destroying life.

"I urge President Obama to direct funding not only to the best science, but also to the surest common ground -- research using adult stem cells and stem cells created by reprogramming."


'/>"/>
SOURCE Family Research Council
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Rallies in Five Cities Planned on Friday the 13th to Protect CA Families From the Bad Budget Deal and Permanent, Deep Cuts to Homecare, Education, and Other Vital Services
2. Dynatronics to Release Second Quarter Results Friday, February 13, 2009; Conference Call set for 1:00 p.m. ET
3. Winner Medical Schedules 2008/2009 First Quarter Earnings Release on Friday, February 13, 2009
4. Registered Nurses and Licensed Practical Nurses at Innova Deptford and Innova Hammonton are Set to Strike at 6 a.m. Friday January 23
5. Dont Disturb Your Circadian Rhythm This Black Friday Sleep In, Nap Later, says Specialty Sleep Association
6. Dynatronics to Release First Quarter Results Friday, November 14, 2008; Conference Call Set for 1:30 p.m. ET
7. China Pharma Holdings, Inc. to Host Third Quarter 2008 Earnings Conference Call at 10 a.m. EST Friday November 7, 2008
8. Labopharm to host conference call Friday, November 7, 2008 at 8:30 a.m. (ET)
9. The Ensign Group Schedules 2008 Third Quarter Earnings Call for Friday, October 31, 2008
10. Hundreds of RNs to Protest CPMC Friday
11. National Alliance for Healthy Communities Sponsors High Desert Health Summit on Friday, October 10th
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... ... December 08, 2016 , ... With the increasing demand for dental ... Your Mouth?” (WIYM) campaign to inform dentists and patients about the safety issues related ... and prosthetic market in the U.S. is projected to reach $6.4 billion in 2018 ...
(Date:12/8/2016)... (PRWEB) , ... December 08, 2016 , ... ... technologies and development solutions for drugs, biologics and consumer health products, today announced ... was set up in 2006 as a non-profit organization to unite pharmaceutical and ...
(Date:12/8/2016)... ... 08, 2016 , ... Healthcare is in flux. The GOP ... the mass media launching of story movements to highlight what's most unfair about ... experiences; such a movement can generate the network power to improve healthcare policies ...
(Date:12/8/2016)... ... December 08, 2016 , ... Peter Zipp Insurance, an ... around the greater Phoenix metropolitan region, is announcing a charity event to provide ... the Homeless Youth Connection is to promote community awareness of the ongoing needs ...
(Date:12/7/2016)... ... 07, 2016 , ... DrugDev again demonstrated its dedication to reducing ... the early adopters completing EU-U.S. Privacy Shield Certification from the U.S. Department of Commerce. ... sides of the Atlantic with a mechanism to comply with EU data protection requirements ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... 2016   TriNetX , the health research ... signed a membership agreement to join the ... new cures. The TriNetX network is ... patients globally, biopharmaceutical companies and contract research organizations ... design, site selection, patient recruitment, and collaborative research ...
(Date:12/8/2016)... , Dec. 8, 2016  Valeant Pharmaceuticals International, ... VRX) ("Valeant") today announced positive results from a ... to assess the safety and efficacy of IDP-118 ... of plaque psoriasis. Within the ... moderate to severe psoriasis, IDP-118 showed statistical significance ...
(Date:12/8/2016)... 8, 2016  EIP Pharma, LLC ( www.eippharma.com ... for neflamapimod (previously code named VX-745), with the ... trials that demonstrated significant Alzheimer,s disease relevant pharmacological ... and Study 303 (6-week treatment) are the subject ... Disease (CTAD) scientific conference in San ...
Breaking Medicine Technology: